InvestorsHub Logo
Followers 101
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Re: Work Harder post# 27171

Monday, 09/05/2022 12:12:50 PM

Monday, September 05, 2022 12:12:50 PM

Post# of 27659
WHO announces new biomanufacturing training hub in South Korea

https://www.devex.com/news/who-announces-new-biomanufacturing-training-hub-in-south-korea-102740

Moderna sets sights on $200M vaccine factory in Seoul: report

https://www.fiercepharma.com/manufacturing/moderna-sets-sights-200m-vaccine-factory-seoul-report

SK bioscience to manufacture Novavax's Omicron COVID-19

https://www.biopharma-reporter.com/Article/2022/07/19/sk-bioscience-to-manufacture-novavax-s-omicron-covid-19-vaccine

South Korea’s Ambition to Become a Global Vaccine Hub

https://thediplomat.com/2021/08/south-koreas-ambition-to-become-a-global-vaccine-hub/

Korea is already home to leading biosimilars producers such as SK Bioscience, GC Pharma, and Samsung Biologics. Korean companies have also figured prominently in the global COVID response, providing contract manufacturing services to diverse vaccine developers.

https://www.weforum.org/agenda/2021/11/south-korea-vaccine-industry-global-trade-policy-tarriffs/

Ph, you may be right in that it was the Mymx biotech consulting firms but it looks so far out that it doesn't matter on that one unless South Korea can manufacture something else for Mymx. Just another total disappointment designed to take the price down right in front of Hiv data. Why would anyone buy common stock w/ that kinda debt the way this company is run.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News